(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 79.82%-237.14K | 114.70%794.2K | -76.72%1.24M | 41.35%3.58M | 69.97%4.24M | -250.66%-1.17M | -1,046.51%-5.4M | 197.57%5.34M | 263.45%2.54M | 417.60%2.49M |
Net income from continuing operations | 110.10%78.69K | 58.17%-657.16K | -2,364.51%-5.17M | -248.91%-2.89M | -92.47%70.51K | -348.97%-778.94K | -149.29%-1.57M | -104.82%-209.86K | -114.33%-828.98K | 173.74%936.5K |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---959.65K |
Depreciation and amortization | 86.43%889.32K | 161.92%725.2K | 44.41%3.08M | 164.65%1.82M | 2.61%498.91K | 31.88%477.02K | -53.31%276.88K | 255.55%2.13M | 74.15%688.8K | 607.61%486.23K |
Asset impairment expenditure | ---- | ---- | 114.80%170.94K | ---- | ---- | ---- | ---- | 83.14%-1.16M | ---- | ---- |
Remuneration paid in stock | 97.43%21.78K | 40.92%25.07K | 351.05%351.32K | 488.39%170.46K | 378.54%152.05K | 26.03%11.03K | 111.91%17.79K | -74.57%77.89K | -90.54%28.97K | --31.77K |
Other non cashItems | 4.00%623.09K | 54.32%450.58K | 1,375.84%1.14M | -413.10%-132.49K | 150.34%378.1K | 67.78%599.14K | 11.18%291.98K | -113.81%-89.1K | -88.27%42.31K | -716.94%-751.12K |
Change In working capital | -24.74%-1.85M | 105.67%250.51K | -63.35%1.68M | 64.14%4.45M | 14.13%3.14M | -1,195.09%-1.48M | -482.20%-4.42M | 270.56%4.58M | 711.20%2.71M | 76.11%2.75M |
-Change in receivables | 355.31%1.02M | 94.14%-57.22K | -29.54%-2.95M | -244.72%-1.07M | 57.47%-499.67K | 15.87%-398.84K | 28.75%-976.59K | 13.27%-2.28M | 148.34%742.6K | -750.62%-1.17M |
-Change in inventory | -692.38%-126.43K | ---121.05K | 66.24%-71.58K | 55.30%-94.77K | --39.14K | ---15.96K | --0 | -1,831.89%-211.99K | -415.71%-211.99K | --0 |
-Change in prepaid assets | 72.56%-66.2K | -357.85%-77.93K | -306.33%-173.63K | -13.86%398.34K | -40.42%-360.9K | -5,538.98%-241.29K | 112.39%30.22K | 79.62%-42.73K | 305.21%462.44K | ---257.02K |
-Change in payables and accrued expense | -223.51%-2.68M | 114.59%506.71K | -31.49%4.87M | 204.15%5.22M | -5.31%3.96M | -327.34%-827.07K | -506.08%-3.47M | 4,385.25%7.12M | 37.06%1.71M | 140.53%4.18M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 79.82%-237.13K | 114.70%794.2K | -76.72%1.24M | 41.35%3.58M | 69.97%4.24M | -240.90%-1.17M | -928.67%-5.4M | 197.57%5.34M | 263.45%2.54M | 417.60%2.49M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 81.11%-398.65K | -3,517.99%-1.89M | -94.64%-15.42M | -167.25%-7.01M | -71.69%-6.36M | -52.12%-2.11M | 126.43%55.39K | -920.03%-7.92M | -1,545.76%-2.62M | -289.79%-3.7M |
Capital expenditure reported | ---- | ---- | -102.89%-15.2M | -209.69%-6.79M | -55.46%-6.36M | ---- | ---- | -864.63%-7.49M | -205.05%-2.19M | ---4.09M |
Net PPE purchase and sale | ---- | -1,553.05%-1.89M | ---- | ---- | ---- | ---- | --130.3K | ---- | ---- | ---- |
Net business purchase and sale | ---- | ---- | ---220K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | 52.14%-74.9K | ---430.23K | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 81.11%-398.65K | -3,517.99%-1.89M | -94.64%-15.42M | -167.25%-7.01M | -71.69%-6.36M | -52.12%-2.11M | 126.43%55.39K | -920.03%-7.92M | -1,545.76%-2.62M | -289.79%-3.7M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -54.44%612.32K | -85.72%1.01M | 294.99%13.24M | 211.18%3.34M | 194.45%1.5M | 490.66%1.34M | 357.88%7.05M | -47.41%3.35M | -34.52%1.07M | 165.51%510K |
Net issuance payments of debt | --0 | --0 | 368.68%3.46M | 414.72%1.53M | --0 | --2.46M | ---524.39K | -86.79%738.57K | -134.45%-486K | 130.44%488K |
Net common stock issuance | ---1M | -0.59%1M | 4.77%1.31M | -40.08%308.07K | --0 | --0 | 59.67%1.01M | 39.04%1.25M | 404.06%514.14K | --0 |
Cash dividends paid | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Proceeds from stock option exercised by employees | --0 | -99.85%6.72K | --6.63M | 17.27%-258.97K | 6,633.12%1.48M | 1,457.04%949.12K | 1,838.10%4.46M | --0 | ---313.04K | --22K |
Interest paid (cash flow from financing activities) | --0 | --0 | ---- | ---- | --0 | --0 | ---12.97K | ---- | ---- | --0 |
Net other financing activities | ---- | ---- | 35.00%1.84M | --1.75M | --20.37K | ---2.06M | 212.33%2.12M | 1,238.97%1.36M | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -54.44%612.32K | -85.72%1.01M | 294.99%13.24M | 211.18%3.34M | 194.45%1.5M | 490.66%1.34M | 357.88%7.05M | -47.41%3.35M | -34.52%1.07M | 165.51%510K |
Net cash flow | ||||||||||
Beginning cash position | -99.03%26.6K | -88.68%118.93K | 273.32%1.05M | 217.22%194.94K | 6.75%811.82K | 163.27%2.75M | 336.17%1.05M | 83.53%281.52K | 505.08%61.45K | -39.49%760.51K |
Current changes in cash | 98.79%-23.47K | -105.42%-92.33K | -221.13%-932.03K | -107.68%-76.01K | 11.76%-616.88K | -495.48%-1.94M | 111.53%1.7M | 500.53%769.44K | 264.64%989.51K | 43.93%-699.06K |
End cash Position | -99.61%3.14K | -99.03%26.6K | -88.68%118.93K | -88.68%118.93K | 217.22%194.94K | 6.75%811.82K | 163.27%2.75M | 273.32%1.05M | 273.32%1.05M | 505.08%61.45K |
Free cash from | 80.32%-635.78K | 79.66%-1.1M | -548.19%-13.95M | -1,028.02%-3.2M | -32.79%-2.12M | -897.63%-3.23M | -834.33%-5.4M | 65.54%-2.15M | 115.20%344.9K | -469.84%-1.6M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data